BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 17121492)

  • 1. Treatment of ANCA-associated systemic vasculitis.
    Belmont HM
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):60-6. PubMed ID: 17121492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ANCA-associated vasculitis].
    Sinico RA; Sabadini E; Boeri R; Radice A
    G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of ANCA associated systemic necrotizing vasculitides].
    Guillevin L
    Bull Acad Natl Med; 2008; 192(6):1175-87; discussion 1188. PubMed ID: 19235481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis.
    Casian A; Jayne D
    Curr Opin Rheumatol; 2011 Jan; 23(1):12-7. PubMed ID: 21124082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: Progress of treatment in ANCA-associated vasculitis.
    Jayne D
    Nephrology (Carlton); 2009 Feb; 14(1):42-8. PubMed ID: 19335843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
    N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.
    Falk RJ; Nachman PH; Hogan SL; Jennette JC
    Semin Nephrol; 2000 May; 20(3):233-43. PubMed ID: 10855933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapies for ANCA-associated vasculitis.
    Lally L; Spiera R
    Annu Rev Med; 2015; 66():227-40. PubMed ID: 25341007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antineutrophil cytoplasmic antibody-associated vasculitides.
    Seo P; Stone JH
    Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials.
    Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V
    Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Kokolina E; Alexopoulos E; Dimitriadis C; Vainas A; Giamalis P; Papagianni A; Ekonomidou D; Memmos D
    Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Churg-Strauss syndrome.
    Keogh KA; Specks U
    Semin Respir Crit Care Med; 2006 Apr; 27(2):148-57. PubMed ID: 16612766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
    Huugen D; Tervaert JW; Heeringa P
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1100-7. PubMed ID: 17699331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
    Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pauci-immune crescentic glomerulonephritis.
    Gupta RK
    Indian J Pathol Microbiol; 2003 Jul; 46(3):357-66. PubMed ID: 15025274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Keogh KA; Wylam ME; Stone JH; Specks U
    Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.